platelet-activ effect low-dens lipoprotein revers isradipin effect calcium antagonist isradipin platelet aggreg induc ex vivo serotonin low-dens lipoprotein ldl nonsmok patient essenti hypertens platelet aggreg four-week placebo period week treatment isradipin serotonin-induc ldl serotonin-induc platelet aggreg week isradipin treatment placebo effect ldl serotonin-induc aggreg signific placebo activ treatment isradipin decreas platelet aggreg ldl serotonin week isradipin treatment amplif serotonin-induc aggreg ldl conclus treatment isradipin restor impair platelet respons ldl hypertens patient inhibit respons cellular mechan thrombovascular protect 